On Thursday, at the Forbes Healthcare Summit in Manhattan, Martin Shkreli said that, given the chance, not only would he raise the price of Daraprim, a drug of particular usefulness to AIDS and cancer patients, to $750 per tablet from $13.50 again, but he’d go even higher.